Healthcare M&A Update Q2 2026
The M&A market for Swiss healthcare providers: High transaction activity, persistent succession pressure and international buyer interest from Canada to Australia.
M&A activity in the Swiss healthcare provider sector accelerated significantly in the first half of 2026. With 23 transactions, activity has already nearly reached the 26 transactions recorded during the full year 2025.
Financial investors acted as buyers in approximately 65% of transactions, while established strategic acquirers also continued to strengthen their market positions through further acquisitions. At the same time, the geographic origin of buyers highlights the international attractiveness of the Swiss healthcare provider market: alongside domestic acquirers, Swiss companies continue to attract interest from international investors – from Canada to Australia.
Key takeaways
- M&A activity in the Swiss healthcare provider sector remains high, supported by a fragmented market and persistent succession pressure.
- Financial investors have represented more than 50% of buyers in every year since 2022.
- The reform of outpatient reimbursement is increasing operational requirements and reinforcing the importance of economies of scale as well as centralized billing and compliance structures.
- Valuations achieved remain attractive, but vary considerably across different healthcare providers and depending on company size.
The combination of structurally resilient demand, a still-fragmented market and increasing operational complexity is expected to continue driving consolidation among Swiss healthcare providers. At the same time, it remains to be seen how current and upcoming changes to the reimbursement system will affect investors’ investment decisions and valuation considerations.
Read our latest Healthcare M&A Update for in-depth insights into M&A activity in the Swiss healthcare sector.
Feel free to reach out to our experts to discuss any questions or areas of interest. We would be pleased to explore how Oaklins can create value for you through our strong international network. Our team is at your disposal to address your specific M&A and corporate finance objectives.
Your contact persons
Partner
View profile
Analyst
View profile